ArunP.WiitaMDPhD

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant Professor, Dept. of Laboratory Medicine

Dr. Wiita is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
185 Berry St
China Basin UCSF Lab Medicine Box 0506
San Francisco, CA 94107
Phone+1 415-353-1469

University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 2009 - 2012
Columbia University Vagelos College of Physicians and SurgeonsClass of 2009
Columbia UniversityPhD, Neurobiology/Biophysics, With Distinction, 2004 - 2008
Princeton UniversityAB, Chemistry, Magna Cum Laude, 1998 - 2002

Dale Frey Breakthrough Award Damon Runyon Cancer Research Foundation, 2015
K08 Mentored Clinical Scientist Award NIH-National Cancer Institute, 2014
Post-Doctoral Fellowship Award Damon Runyon Cancer Research Foundation, 2012
Dean's Award for Excellence in Research (top PhD thesis prize) Columbia University College of Physicians and Surgeons, 2008
Join now to see all

PubMed

149 citations
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.
Anum A. Glasgow, Jeff E. Glasgow, Daniel Limonta, Paige Solomon, Irene Lui
Proceedings of the National Academy of Sciences of the United States of America. 2020-11-10
329 citations
Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway
Xiaoyan Guo, Giovanni Aviles, Yi Liu, Ruilin Tian, Bret A. Unger
Nature. 2020-03-04
274 citations
The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles.
Andrew M. Leidal, Hector H. Huang, Timothy Marsh, Tina Solvik, Dachuan Zhang
Nature Cell Biology. 2020-01-13

Abstracts/Posters

Ifitm3 Is Essential for PI(3,4,5)P3-Dependent B-Cell Activation and Leukemogenesis
Arun P. Wiita, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell Malignancies
Arun P. Wiita, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and _Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and Biology
Arun P. Wiita, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Signaling Input from Divergent Pathways Subverts Malignant B-Cell Transformation
Arun P. Wiita, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Identifying Factors in Multiple Myeloma Controlling Response to B-Cell Maturation Antigen (BCMA)-Targeted Immunotherapy Using CRISPR-Based Functional Genomics
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hutch Scientists Receive $25M to Solve Breast Cancer MetastasisJuly 27th, 2022
Research Round-up: Multiple MyelomaNovember 25th, 2020
Innovative Indian American Researchers Named 2016 NIH ‘New Innovator Award Program’ RecipientsOctober 28th, 2016